The PRNP Gene Huntington Disease-like Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the PRNP gene associated with Huntington Disease-like 1 (HDL1). HDL1 is a rare neurodegenerative disorder that shares clinical features with Huntington's disease, including movement disorders, psychiatric symptoms, and cognitive decline, but is caused by different genetic abnormalities. This particular test focuses on identifying the specific mutations in the PRNP gene, which is critical for accurate diagnosis and differentiation from other similar conditions.
Priced at 4400 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, where advanced genetic testing technologies are utilized to ensure high accuracy and reliability of the results. This test is crucial for families with a history of HDL1, as it not only aids in confirming the diagnosis but also helps in understanding the risk of passing the mutation to the next generation. Early and precise diagnosis through the PRNP Gene Huntington Disease-like Type 1 Genetic Test can significantly impact the management and treatment strategies for affected individuals, providing them with a better quality of life.
The JPH3 gene Huntington Disease-like Type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the JPH3 gene, which are associated with Huntington Disease-like 2 (HDL2). HDL2 is a rare neurodegenerative disorder that shares many clinical features with Huntington's disease, including movement disorders, psychiatric disturbances, and cognitive decline. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the JPH3 gene can lead to the disease.
This test is crucial for individuals with a family history of HDL2 or those exhibiting symptoms suggestive of Huntington's disease but who have tested negative for the more common HTT gene mutation associated with Huntington's. Early and accurate diagnosis through the JPH3 gene test can facilitate better management of the condition, allow for genetic counseling, and inform family planning decisions.
The test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test, patients and their families can gain valuable insights into their genetic status and take proactive steps in managing their health.
The PRNP Gene Gerstmann-Straussler Disease Genetic Test is a specialized diagnostic procedure designed to detect mutations in the PRNP gene, which are associated with Gerstmann-Straussler-Scheinker (GSS) disease. GSS is a rare, inherited neurodegenerative disorder characterized by ataxia, dementia, and various neurological symptoms, resulting from the abnormal accumulation of prion proteins in the brain. The test involves analyzing the patient's DNA to identify specific genetic alterations in the PRNP gene that are linked to the development of GSS.
Conducted at DNA Labs UAE, this genetic test is crucial for individuals with a family history of GSS or those presenting symptoms suggestive of prion diseases. Early and accurate diagnosis through genetic testing can aid in the management of the disease, although there is currently no cure. Counseling may also be recommended to discuss the implications of the test results for the patient and their family.
The cost of the PRNP Gene Gerstmann-Straussler Disease Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the genetic analysis, professional fees, and post-test counseling. It's important for patients to consult with their healthcare providers to understand the potential benefits, limitations, and risks associated with the test before proceeding.
The GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, aimed at detecting mutations in the GAN gene, which are responsible for Giant Axonal Neuropathy (GAN) Type 1. This rare, inherited neurological disorder is characterized by a progressive decline in nerve function, affecting both the central and peripheral nervous systems. Symptoms typically emerge in early childhood and can include muscle weakness, motor skill regression, and in severe cases, impairment of sensory functions.
The test is crucial for early diagnosis and management of the condition, offering insights into potential treatments and interventions that can improve quality of life. Conducted through a detailed analysis of the patient's DNA, it seeks to identify specific genetic alterations in the GAN gene that confirm the diagnosis of GAN Type 1.
The cost of the GAN Gene Giant Axonal Neuropathy Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive genetic screening process, leveraging advanced technology and expertise to ensure accurate and reliable results. Given the complexity and rarity of the condition, this genetic test represents a critical step towards personalized care and management for affected individuals and their families.
The "ITPR1 Gene Gillespie Syndrome Genetic Test" is a specialized diagnostic procedure conducted to detect mutations in the ITPR1 gene, which are linked to Gillespie Syndrome, a rare genetic disorder. This syndrome is characterized by partial aniridia (a condition where the iris is partially absent), ataxia (lack of muscle coordination), and intellectual disability. The test is crucial for confirming the diagnosis, enabling early intervention, and providing targeted management to affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the ITPR1 gene to identify any genetic abnormalities that may be responsible for the syndrome. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately diagnose this rare condition. Through this test, families and healthcare providers can gain valuable insights into the genetic basis of Gillespie Syndrome, facilitating informed decisions about care and support for those affected.
The GCSH Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GCSH gene, which are associated with Glycine Encephalopathy, also known as Non-Ketotic Hyperglycinemia (NKH). This condition is a rare but severe metabolic disorder that affects the brain and nervous system, leading to a wide range of neurological symptoms. Early detection through genetic testing is crucial for managing the condition and providing appropriate treatment to improve the quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the GCSH Gene Glycine Encephalopathy Genetic Test is 4400 AED. This comprehensive test involves analyzing the patient's DNA to look for specific mutations in the GCSH gene that are known to cause Glycine Encephalopathy. By identifying these mutations, healthcare providers can confirm a diagnosis, understand the severity of the condition, and tailor treatment plans accordingly. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, making it a trusted choice for genetic testing in the region.
The MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the MGAT2 gene. These mutations are responsible for a rare condition known as Congenital Disorder of Glycosylation Type IIa (CDG-IIa), which affects the body's ability to properly attach sugar molecules to proteins (glycosylation). This disorder can lead to a wide range of symptoms, including developmental delay, intellectual disabilities, and abnormalities in various organs.
The test is conducted through a comprehensive analysis of the patient's DNA, specifically targeting the MGAT2 gene to identify any genetic alterations. Given the complexity and precision of the testing process, the cost for this genetic test is set at 4400 AED. DNA Labs UAE utilizes advanced genomic technologies to ensure accurate and reliable results, providing essential information for the diagnosis, management, and potential treatment of this genetic condition. This test is crucial for families seeking answers to unexplained symptoms related to glycosylation disorders, offering a path towards better understanding and management of the condition.
The ALG6 Gene Glycosylation Disorder Type 1C Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the ALG6 gene. These mutations are responsible for a type of Congenital Disorders of Glycosylation (CDG), specifically Type 1C, a rare genetic condition. CDGs are a group of inherited metabolic disorders that affect the glycosylation process, where sugars are attached to proteins and lipids, impacting multiple systems in the body including the nervous system, immune system, and gastrointestinal system.
This test, priced at 4400 AED, involves analyzing the patient's DNA to detect any abnormalities in the ALG6 gene that may lead to the disorder. Early detection through this genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, providing essential information for the diagnosis, treatment planning, and family genetic counseling of ALG6-CDG Type 1C.
The DPAGT1 gene glycosylation disorder type 1J genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DPAGT1 gene. These mutations can lead to a rare condition known as Congenital Disorder of Glycosylation Type 1j (CDG-1j), which affects the normal process of glycosylation, an essential biological mechanism where sugar molecules are attached to proteins and lipids, impacting their stability and function. This disorder can present with a wide range of symptoms, including developmental delay, neurological issues, and problems with the digestive system, among others.
Given the complexity of CDG-1j and the importance of early diagnosis for managing the condition, the test provided by DNA Labs UAE is crucial for families with a history of the disorder or presenting symptoms. At a cost of 4400 AED, the test is conducted using advanced genetic sequencing techniques to ensure accuracy and reliability in detecting any mutations in the DPAGT1 gene. Results from this test can provide essential information for diagnosis, allowing healthcare providers to develop a tailored management and treatment plan for affected individuals.
The DOLK Gene Glycosylation Disorder Type 1M Genetic Test is a specialized diagnostic assessment designed to identify mutations in the DOLK gene, which can lead to Congenital Disorders of Glycosylation Type 1m (CDG-1m). This condition is a rare genetic disorder that affects the normal process of glycosylation, the attachment of sugars to proteins and lipids, which is crucial for various cellular functions. Mutations in the DOLK gene disrupt this process, leading to a range of symptoms including developmental delay, skin abnormalities, and potential issues with the heart, liver, and muscles.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. Utilizing advanced genetic sequencing technologies, the test examines the DOLK gene for specific mutations known to cause the disorder. This precise approach allows for an accurate diagnosis, which is essential for developing an effective treatment plan and providing genetic counseling.
The cost of the DOLK Gene Glycosylation Disorder Type 1M Genetic Test is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions that can significantly improve the quality of life for affected individuals. Additionally, the test provides vital information for family planning and the assessment of risk for future children.
